MAZE THERAPEUTICS, INC. (MAZE) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading MAZE…

MAZE THERAPEUTICS, INC. (MAZE) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

MAZE THERAPEUTICS, INC.

MAZE · CIK 1842295

4 · Sep 8, 2026 · President, R&D & CMO Bernstein Harold sold 9,705 shares at $26.22/share ($254.5K)

4

President, R&D & CMO Bernstein Harold sold 9,705 shares at $26.22/share ($254.5K)

Filed: Sep 8, 2026
Period: Sep 4, 2026
Accession: 0002050172-26-000036
Filer: Maze Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/form4-09082026_080930.xml

xslF345X06/form4-09082026_080930.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4form4-09082026_080930.xml
Open SEC.gov